Core Laboratories Z Score
CLB  Stock  USD 20.13 1.55 7.15% 
Core Laboratories  Z Score 
Core Laboratories Z Score Analysis
Core Laboratories' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2019  2020  2021  2022 (projected)  
Interest Expense  14.69 M  14.37 M  9.15 M  11.44 M 
Gross Profit  172.63 M  112.5 M  102.36 M  157.06 M 
Z Score  =  Sum Of   5 Factors 
Current Core Laboratories Z Score  1.8 
Most of Core Laboratories' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Core Laboratories Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
In accordance with the company's disclosures, Core Laboratories NV has a Z Score of 1.8. This is 19.28% lower than that of the Energy Equipment & Services sector and 5.88% higher than that of the Energy industry. The z score for all United States stocks is 79.36% higher than that of the company.
Core Laboratories Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.Core Laboratories is currently under evaluation in z score category among related companies.
Core Laboratories Current Valuation Drivers
We derive many important indicators used in calculating different scores of Core Laboratories from analyzing Core Laboratories' financial statements. These drivers represent accounts that assess Core Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Core Laboratories' important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Average Assets  582.93 M  629.33 M  783.91 M  605.11 M  587.5 M  674.84 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  136.63 M  141.39 M  126.99 M  (56.5 M)  63.29 M  64.95 M  
Earnings Before Interest Taxes and Depreciation Amortization USD  136.63 M  141.39 M  126.99 M  (56.5 M)  63.29 M  64.95 M  
Earnings before Tax  101.37 M  104.97 M  89.69 M  (91.74 M)  35.62 M  36.56 M  
Average Equity  147.78 M  153.9 M  184.88 M  66.74 M  151.23 M  138.05 M  
Enterprise Value  5.06 B  2.92 B  2.03 B  1.5 B  1.27 B  1.3 B  
Free Cash Flow  105.82 M  89.78 M  67.97 M  47.22 M  23.4 M  24.02 M  
Invested Capital  508.38 M  590.47 M  802.9 M  683.97 M  615.05 M  677.71 M  
Invested Capital Average  507.54 M  568.48 M  791.85 M  711.4 M  630.07 M  676.48 M  
Market Capitalization  4.84 B  2.64 B  1.67 B  1.18 B  1.03 B  1.06 B  
Tangible Asset Value  396.37 M  416.36 M  543.8 M  460.55 M  473.27 M  512.29 M  
Working Capital  106.85 M  128.43 M  109.64 M  76.1 M  98.27 M  103.68 M 
Core Laboratories Fundamentals
Return On Equity  9.19 %  
Return On Asset  0.044 %  
Profit Margin  0.0316 %  
Operating Margin  0.08 %  
Current Valuation  1.19 B  
Shares Outstanding  46.37 M  
Shares Owned by Insiders  0.51 %  
Shares Owned by Institutions  99.49 %  
Number of Shares Shorted  4.08 M  
Price to Earning  101.74 X  
Price to Book  5.43 X  
Price to Sales  1.98 X  
Revenue  470.25 M  
Gross Profit  102.36 M  
EBITDA  63.29 M  
Net Income  20.22 M  
Cash and Equivalents  17.7 M  
Cash per Share  0.29 X  
Total Debt  188.64 M  
Debt to Equity  1.29 %  
Current Ratio  2.23 X  
Book Value Per Share  3.85 X  
Cash Flow from Operations  36.58 M  
Short Ratio  8.45 X  
Earnings Per Share  0.33 X  
Price to Earnings To Growth  0.53 X  
Target Price  20.89  
Number of Employees  3.6 K  
Beta  2.63  
Market Capitalization  964.99 M  
Total Asset  580.85 M  
Retained Earnings  213.91 M  
Working Capital  117.79 M  
Current Asset  238.55 M  
Current Liabilities  120.76 M  
Z Score  1.8  
Annual Yield  0.002 %  
Five Year Return  2.66 %  
Net Asset  580.85 M  
Last Dividend Paid  0.04 
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fund Screener Now
Fund ScreenerFind activelytraded funds from around the world traded on over 30 global exchanges 
All Next  Launch Module 
Pair Trading with Core Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving together with Core Laboratories
+  0.78  ARCH  Arch Resources  Normal Trading  PairCorr  
+  0.77  CLR  Continental Resources  Delisting  PairCorr  
+  0.93  CVE  Cenovus Energy  Potential Growth  PairCorr  
+  0.9  CVI  CVR Energy  Downward Rally  PairCorr 
The ability to find closely correlated positions to Core Laboratories could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Continue to Core Laboratories Piotroski F Score and Core Laboratories Valuation analysis. You can also try Performance Analysis module to check effects of meanvariance optimization against your current asset allocation.
Complementary Tools for analysis
When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Volatility AnalysisGet historical volatility and risk analysis based on latest market data  Go  
Portfolio RebalancingAnalyze riskadjusted returns against different time horizons to find assetallocation targets  Go  
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios  Go  
Global CorrelationsFind global opportunities by holding instruments from different markets  Go  
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings  Go 
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY 7.47  Market Capitalization 965 M  Quarterly Revenue Growth YOY 0.068  Return On Assets 0.044  Return On Equity 9.19 
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.